C-MO6FTAZ Inc.
senolytics, epigenetic age, biomarkers
clearingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-MO6F
C-MO6FC-MO6Fsenolytics, epigenetic age, biomarkers
0-100 chain-logic scale · 15 dimensions · scored on public evidence
TAZ Inc. senolytics, epigenetic age, biomarkers
TAZ Inc. is a University of Tokyo-origin biotechnology startup founded by researchers specializing in life sciences and molecular nutrition. The company works on anti-aging product planning, senescent cell removal assays, calorie restriction mimetic screening, biomarkers for age-related diseases, epigenetic age testing, and drug discovery. Its mission is to use science and technology to address aging-related challenges and help people live healthier, longer lives.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
TAZ Inc. — Far from goals · Bottom quartile. Derived deterministically from 6 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…
Source: Deterministic